Dimension Bio

Geography: Chicago

Indication: Bone grafts; End-stage liver failure

Stage: 510(k) clearance

Leadership: Caralynn Nowinski

Dimension Bio is developing a new generation of regenerative therapeutics by engineering 3D microenvironments that direct cell behavior to restore tissue and organ function. Its lead product, CMFlex, is a synthetic bone graft that has received FDA clearance for maxillofacial reconstruction surgery. In addition, Dimension Inx is advancing a hepatic tissue therapeutic for acute liver failure, leveraging its biomaterial platform to enable precise cellular interactions and tissue regeneration.

Visit Site